TOP-Zn Steric Hindrance Effect Enables Ultra-Uniform CsPbX3 Quantum Dots for Wide-Color Gamut Displays

© 2025 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 37(2025), 20 vom: 19. Mai, Seite e2409308
1. Verfasser: Lv, Xinyi (VerfasserIn)
Weitere Verfasser: Su, Yuqin, Xiang, Hengyang, Yang, Linxiang, Chen, Xinrui, Wang, Yifei, Zhang, Kun, Tang, Jiahao, Ye, Yuhui, Cai, Bo, Ma, Xueying, Wang, Xiaoyong, Zeng, Haibo
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2025
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article FWHM narrowing TOP‐Zn complex light‐emitting diodes nucleation‐growth perovskite quantum dots
Beschreibung
Zusammenfassung:© 2025 Wiley‐VCH GmbH.
Perovskite quantum dots (PQDs) are expected to be an ideal candidate for wide-color gamut displays owing to their high color purity. However, their color purity is challenged by remarkable spectral broadening due to non-uniform size distribution and crystal defects. Here, a ligand-ion (TOP-Zn) complex-modulating nucleation strategy is proposed to depress spectral broadening. This is achieved by enhancing the steric hindrance effect during lead-halogen octahedral assembly and reducing the reaction activity/sites of the system. This strategy is universal and has been confirmed to be effective for blue, green, and red PQDs, achieving narrowed spectral full-width-at-half-maximum (FWHM) of 15, 17, and 25 nm, respectively. These FWHMs are record-breaking and contribute to a wide color gamut coverage of ≈130% National Television Standards Committee and ≈100% Rec. 2020 standard. Meanwhile, these PQD-based light-emitting diodes (PeLEDs) exhibit a high external quantum efficiency (EQE) of exceeding 20% at their pure color range. These results provide a feasible path to achieve ultra-uniform and pure-color luminescent PQDs for wide-color gamut displays
Beschreibung:Date Revised 19.05.2025
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202409308